Clinical Trial Type: Lung

Name of this trial: DeLLphi-315 What type of cancer is this for? ES-SCLC (extensive-stage, small cell lung cancer) Who is this trial for?  Patients who have progressed after initial treatment of chemotherapy with or without anti-PD (L)1 therapy. What biomarkers are involved? N/A What is the National Clinical Trial #? NCT07778316   https://clinicaltrials.gov/study/NCT07778316?term=NCT07778316&viewType=Card&rank=1 Brief summary of this trial: Phase 3 randomized trial of subcutaneous